← Leaderboards
Yunfeng Chen
Scripps Research Institute, The
$1,388,793
Attributed
$1,388,793
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $440K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,388,793 · 3
By mechanism
R00$746,439 · 1
R35$440,000 · 1
K99$202,354 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Laurent Olivier Mosnier$14,213,468
- Nicole Franziska Steinmetz$15,228,645
- Douglas A Lauffenburger$27,665,222
- Thomas Lavstsen$672,417
- Taisuke Kanaji$2,137,520
Others in their field
Other Emerging Leaders on “In Vitro”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Leonard Freedmand · Leidos Biomedical Research, Inc.$68,796,314
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
- John Damon Chodera · Sloan-Kettering Inst Can Research$34,949,884
- Tony Moody · Duke University$34,777,314
Research focus
In VitroMediatingReceptorIntegrinsMolecularBiomechanicsAdhesionsClinical TreatmentDiabetes MellitusBiologyAwardBiomedical EngineeringAmericanBlood CoagulationCrosslinkDesignBlood VesselsBlood PlateletsBiochemicalArteriesCareerCareer DevelopmentBindingBlood Flow
Grant awards (6)
Deciphering Mechanosignaling Using Multi-fluorescence Biomembrane Force Probe$440,000
R35 · FY2025 · GM · contact PI
Inhibiting biomechanical platelet aggregation to prevent arterial thrombosis without compromising hemostasis$248,792
R00 · FY2024 · HL · contact PI
Inhibiting biomechanical platelet aggregation to prevent arterial thrombosis without compromising hemostasis$248,792
R00 · FY2023 · HL · contact PI
Inhibiting biomechanical platelet aggregation to prevent arterial thrombosis without compromising hemostasis$248,855
R00 · FY2022 · HL · contact PI
Inhibiting biomechanical platelet aggregation to prevent arterial thrombosis without compromising hemostasis$101,177
K99 · FY2021 · HL · contact PI
Inhibiting biomechanical platelet aggregation to prevent arterial thrombosis without compromising hemostasis$101,177
K99 · FY2020 · HL · contact PI